LIFE - Atyr Pharma Inc
Close
1.9
0.050 2.632%
Share volume: 269,477
Last Updated: Tue 04 Jun 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.85
0.05
2.70%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-15 | 2022-11-14 | 2023-03-14 | 2023-05-09 | 2023-08-09 | 2023-11-09 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 10.386 M | 0.000 | 0.000 | 353.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 10.386 M | 0.000 | 0.000 | 353.000 K | |
| nan% | nan% | inf% | -100.00% | nan% | inf% | |||
| Operating expenses | 12.378 M | 12.584 M | 13.492 M | 18.336 M | 12.787 M | 13.558 M | 12.968 M | |
| Selling general and admin | 3.482 M | 3.449 M | 3.625 M | 3.426 M | 3.408 M | 3.718 M | 2.649 M | |
| Research and development | 8.896 M | 9.135 M | 9.867 M | 14.910 M | 9.379 M | 9.840 M | 10.319 M | |
| Total expenses | 12.378 M | 12.584 M | 13.492 M | 18.336 M | 12.787 M | 13.558 M | 12.968 M | |
| 1.66% | 7.22% | 35.90% | -30.26% | 6.03% | -4.35% | |||
| Operating income | -12.378 M | -12.584 M | -13.492 M | -7.950 M | -12.787 M | -13.558 M | -12.615 M | |
| Ebit | -12.378 M | -12.584 M | -13.492 M | -7.950 M | -12.787 M | -13.558 M | -12.615 M | |
| Pretax income | -12.154 M | -12.421 M | -13.245 M | -7.523 M | -11.952 M | -12.342 M | -11.342 M | |
| 2.20% | 6.63% | -43.20% | 58.87% | 3.26% | -8.10% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -12.153 M | -12.420 M | -13.244 M | -7.521 M | -11.951 M | -12.338 M | -11.340 M | |
| -2.20% | -6.63% | 43.21% | -58.90% | -3.24% | 8.09% | |||
| Net income | -12.153 M | -12.420 M | -13.244 M | -7.521 M | -11.951 M | -12.338 M | -11.340 M | |
| -2.20% | -6.63% | 43.21% | -58.90% | -3.24% | 8.09% |